E
Evangelos Terpos
Researcher at National and Kapodistrian University of Athens
Publications - 858
Citations - 33515
Evangelos Terpos is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Multiple myeloma & Medicine. The author has an hindex of 73, co-authored 725 publications receiving 25857 citations. Previous affiliations of Evangelos Terpos include Hammersmith Hospital & Imperial College London.
Papers
More filters
Journal ArticleDOI
Selective HDAC6 Inhibitor ACY-241, an Oral Tablet, Combined with Pomalidomide and Dexamethasone: Safety and Efficacy of Escalation and Expansion Cohorts in Patients with Relapsed or Relapsed-and-Refractory Multiple Myeloma (ACE-MM-200 Study)
Ruben Niesvizky,Paul G. Richardson,Andrew Yee,Ajay K. Nooka,Marc S. Raab,Kenneth H. Shain,Nashat Y. Gabrail,Jeffrey Matous,Amit Agarwal,James E. Hoffman,Sumit Madan,John M. Pagel,Jesus San Miguel,Philippe Moreau,Maria-Victoria Mateos,Thierry Facon,David Tamang,Simon S. Jones,Robert J Markelewicz,Catherine Wheeler,Nikolaus S. Trede,Noopur Raje,Evangelos Terpos,William I. Bensinger +23 more
TL;DR: New data is presented on safety and efficacy of the ACY-241/Pom/Dex combination in patients with relapsed or relapsed-and-refractory multiple myeloma and the recommended dose for further development.
Journal ArticleDOI
Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget’s disease of bone
Stergios A. Polyzos,Jannis Kountouras,A. D. Anastasilakis,Ioannis Litsas,Marina Kita,Georgios Arsos,Efstratios Moralidis,Evangelos Terpos +7 more
TL;DR: The case of a patient with Paget’s disease of bone accompanied by nonalcoholic fatty liver disease who developed transient hepatotoxicity after zoledronic acid (ZOL) treatment is described, and physicians should be aware of this possible adverse effect and ZOL cautiously administered in NAFLD patients.
Journal ArticleDOI
Angiogenetic Factors and Biochemical Markers of Bone Metabolism in POEMS Syndrome Treated with High-Dose Therapy and Autologous Stem Cell Support
Efstathios Kastritis,Evangelos Terpos,Athanasios Anagnostopoulos,Irini Xilouri,Meletios A. Dimopoulos +4 more
TL;DR: Serum levels of angiogenic cytokines along with a series of bone remodeling indices were measured in patients with POEMS before and after high-dose therapy (HDT) with autologous stem cell transplantation and in age- and sex-matched controls.
Journal ArticleDOI
Continuous increase in erythropoietic activity despite the improvement in bone mineral density by zoledronic acid in patients with thalassemia intermedia-induced osteoporosis.
TL;DR: The aim of this study was to evaluate the erythropoietic activity in patients with TI-induced osteoporosis who received zoledronic acid or placebo and to explore possible correlations of bone marrow expansion with bone mineral density (BMD) of TI patients during the study period.
Journal ArticleDOI
Leukemogenic Risk of Hydroxyurea Therapy as a Single Agent in Polycythemia Vera and Essential Thrombocythemia: N-and K-ras Mutations and Microsatellite Instability in Chromosomes 5 and 7 in 69 Patients
Despina Mavrogianni,Nora Viniou,Evi Michali,Evangelos Terpos,John Meletis,George Vaiopoulos,Marina Madzourani,Gerasimos Pangalis,Xenophon Yataganas,Dimitris Loukopoulos +9 more
TL;DR: Results indicate that microsatellite instability (MSI) is a genetic marker that can be detected, even in a small group of patients, at the blastic phase of the disease and no increased leukemogenicity was noted in this group of Patients treated with HU.